Article Listing - Novartis takes $120 million charge as it drops vadimezan development

HOECHST DEFENDS NOMIFENSINE IN SUIT

16 March 1992

The German drugs major Hoechst AG is defending itself against allegations linked to claimed side effects of the company's antidepressant...

ARES-SERONO Rx DRUG SALES UP 15.5%

16 March 1992

On group sales of $751.1 million for the year ended December 31, 1991 (reported in brief last week), Swiss-based Ares-Serono...

US ORPHAN DRUG CHANGE "WOULD BE VETOED"

16 March 1992

The US Bush Administration is strongly opposed to S 2060, the Senate legislation which proposes to end the market monopoly...

FRENCH DOCTORS ATTACK COST DEAL

16 March 1992

The French general practitioners' union, MG-France, has warned of the effects which the health cost control deal just agreed between...

LIFEGrOUP CHANGES ACQUISITION PLAN

16 March 1992

After a long period of analysis and negotiation, Italy's LIFEGROUP, founded in 1991, has decided against proceeding with the planned...

PHARMA UNIT SALE LIFTS GIST-BROCADES

16 March 1992

Excluding the pharmaceuical division which it sold to Yamanouchi last year, Dutch company Gist-Brocades saw turnover for 1991 increase by...

BBG'S DETECTION KITS

16 March 1992

- British Bio-technology Prod-ucts Ltd has expanded its range of in situ hybridization products to include a Detection Module for...

TAMOXIFEN TRIAL IN MEN

16 March 1992

- Imperial Chemical Indus-tries' Nolvadex (tamoxifen) is prolonging the lives of men with breast cancer, according to results of a...

GENZYME AND GLYCOPROTEINS

16 March 1992

- Genzyme Corp, in collaboration with Robert Van Etten and colleagues at Purdue University, Indiana, has developed technol-ogy which could...

COMBO THERAPY FOR LEISHMANIASIS

16 March 1992

- The combination of allopurinol and meglumine antimoniate is more effective than the latter alone for American cutaneous leishmaniasis, according...

Showing 94591-94600 of 95337 articles

Go to beginningPreviousNextGo to end